TAOX
Price:
$6.67
Market Cap:
$23.26M
Clinical-stage biopharmaceutical company developing a bryostatin‑1 platform for Alzheimer’s and other neurodegenerative/cognitive diseases. Also pivoting to a digital-asset treasury strategy focused on acquiring and staking TAO cryptocurrency.
Industry
Biotechnology
IPO Date
2025-07-02
Stock Exchange
NASDAQ
Ticker
TAOX
According to TAO Synergies Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.47. This represents a change of -163.76% compared to the average of 0.74 of the last 4 quarters.
The mean historical PE Ratio of TAO Synergies Inc. over the last ten years is -0.14. The current -0.47 PE Ratio has changed 32.71% with respect to the historical average. Over the past ten years (40 quarters), TAOX's PE Ratio was at its highest in in the March 2025 quarter at 3.60. The PE Ratio was at its lowest in in the March 2024 quarter at -5.02.
Average
-0.14
Median
-0.13
Minimum
-0.31
Maximum
0
Discovering the peaks and valleys of TAO Synergies Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 215.31%
Maximum Annual PE Ratio = 0
Minimum Annual Increase = -100.00%
Minimum Annual PE Ratio = -0.31
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | 0 | -100.00% |
| 2023 | -0.31 | 53.90% |
| 2022 | -0.20 | 215.31% |
The current PE Ratio of TAO Synergies Inc. (TAOX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-0.17
5-year avg
-0.14
10-year avg
-0.14
TAO Synergies Inc.’s PE Ratio is less than Sonnet BioTherapeutics Holdings, Inc. (-0.37), greater than Rallybio Corporation (-0.72), greater than Plus Therapeutics, Inc. (-3.42), greater than Intensity Therapeutics, Inc. (-1.69), greater than iBio, Inc. (-3.37), less than Boundless Bio, Inc. (-0.38), greater than NextCure, Inc. (-0.50), greater than Klotho Neurosciences, Inc. (-2.58), greater than Iterum Therapeutics plc (-0.75), greater than Cadrenal Therapeutics, Inc. Common Stock (-1.58),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.37 | $8.43M | |
| -0.72 | $28.16M | |
| -3.42 | $39.62M | |
| -1.69 | $21.70M | |
| -3.37 | $21.16M | |
| -0.38 | $24.62M | |
| -0.50 | $34.11M | |
| -2.58 | $25.82M | |
| -0.75 | $21.14M | |
| -1.58 | $23.04M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TAO Synergies Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like TAO Synergies Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is TAO Synergies Inc.'s PE Ratio?
How is the PE Ratio calculated for TAO Synergies Inc. (TAOX)?
What is the highest PE Ratio for TAO Synergies Inc. (TAOX)?
What is the 3-year average PE Ratio for TAO Synergies Inc. (TAOX)?
What is the 5-year average PE Ratio for TAO Synergies Inc. (TAOX)?
How does the current PE Ratio for TAO Synergies Inc. (TAOX) compare to its historical average?